Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-12 · accession 0001867096-24-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-08-13 | 2024-08-12 | XERS | Schmid John P. | Dir | P - Purchase | $2.25 | +4,515 | 25.2K | +22% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | P | A | 4,515 | $2.25 | 25,200 | I By: The Schmid Family Trust dated August 15, 2017 | — | — | (F1) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |